Vancomycin-induced severe thrombocytopenia in a young infant
Rev. Soc. Bras. Med. Trop
; 51(6): 873-875, Nov.-Dec. 2018. tab, graf
Article
en En
| LILACS
| ID: biblio-977108
Biblioteca responsable:
BR1.1
ABSTRACT
Abstract Vancomycin is a first-line drug for treating methicillin-resistant Staphylococcus aureus. Thrombocytopenia is a rare adverse reaction to vancomycin treatment, and there are no reports of vancomycin-induced thrombocytopenia (VIT) in infants. We describe the case of a 3-month-old girl who was diagnosed with purulent meningitis. After 13 days of treatment with vancomycin, her platelet count reduced to 8 × 109/L. Vancomycin was discontinued, and intravenous methylprednisolone was administered. The platelet count returned to normal after 4 days. Patients, especially young children, receiving vancomycin for a long clinical course should undergo careful monitoring of laboratory indicators and blood tests.
Palabras clave
Texto completo:
1
Índice:
LILACS
Asunto principal:
Trombocitopenia
/
Vancomicina
Tipo de estudio:
Diagnostic_studies
Límite:
Female
/
Humans
/
Infant
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
MEDICINA TROPICAL
Año:
2018
Tipo del documento:
Article